Tissue/Organ

Wyss Institute and Cytosurge collaborate on CRISPR tech

The Wyss Institute at Harvard is joining forces with Swiss Biotech Cytosurge in a bid to improve CRISPR-based multiplexed gene editing with a single-cell...

Longevity and the art of motorcycle maintenance

OpenCures' Kevin Perrott talks about empowering the consumer with their own health data. One of the Longevity sector’s leading voices came to the field relatively...

Juvenescence CEO on near-term Longevity breakthroughs

We talk pipeline, trials, raising capital and public company challenges with Juvenescence's Dr Greg Bailey. Longevity.Technology: Longevity is growing as a distinct investment category and Thursday’s...

Longevity 2020: shaping-up nicely

Over 45 confirmed speakers for this 5-day online event and a big thank you for your interest. We're moving fast! Longevity 2020 started just over...

Some good news: announcing Longevity2020

In these challenging times, with everyone working from home and conferences pushed-back to later this year, we had an idea: Longevity2020 While the world overcomes...

Fishing for regenerative therapies

Talking Longevity, indication expansion, killifish and regeneration with Dr Aric Rogers from the MDI Biological Laboratory. Nestled on the picturesque coastline of Maine, USA, the...

New imaging technique progresses organ growth

A new breakthrough has created transparent organs which could support improved organ growth and solve the global organ donation crisis. We often hear calls for...

Hormone producing organoids to halt age-related disease

JangoBio claims a scientific breakthrough in developing sustainable stem-cell based organoids for hormone restoration. Having recently closed a $2m seed round, researchers at JangoBio's Wisconsin...

EnClear bags $10m to start first in-human

We talk exclusively with the Longevity start-up targeting neurodegenerative disease with novel therapeutic filtration (device) technology. Its mission: access and control cerebrospinal fluid to get...

Bioengineering breakthrough for patching broken hearts

Bioengineering team from Trinity College in Dublin develops a prototype patch that does the same job as crucial aspects of heart tissue. One in six men...

J&J enters Longevity market with “Immorbidity” play

A new competition aims to find the next great breakthrough to help us stay active and healthy beyond the age of 100. People are living...

Proteomics and biological age measurement

AgeCurve closes in on first round investment as it builds its team with the support of key opinion leaders in aging research. UK start-up AgeCurve...

“Human-on-a-Chip” OOC to revolutionise preclinical

New system of linked mini-organs heralds a new era of comprehensive drug testing that is faster and more efficient than anything seen before. OOC...

Lab-grown muscle in heart transplant breakthrough

Japanese research team announces world-first. Lab-grown heart muscles created from induced pluripotent stem (iPS) cells successfully transplanted into a human: a new take on...

Aspect Biosystems talks regeneration

Finding out what’s behind the $20m bioprinting start-up. Vancouver-based Aspect Biosystems recently closed a $20 million funding round, making it one of the world’s most...

Innovating organ-on-chip to accelerate research

BIOFABICS brings custom design tools to biofabrication. While still in its infancy, organ-on-chip (OOC) technology is quickly becoming a key growth segment in the Longevity...

Aspect Biosystems raises $20m for human bioprinting

Further boost for 3D bio-printing sector as Aspect Biosystems announces a multimillion funding round for advanced therapies. Biotechnology company and pioneer in the 3D printing...

Xenotransplant pigs organs one-step closer

Scientists are moving closer to creating first human transplant organs from pigs. More than 100,000 people are on the organ transplant waiting list in the US...

AI-built “living machine” is world first

Evolved by AI algorithms from frog cells into something not remotely Kermit-like, this living machine is a real leap forward for Longevity. Forget everything you...

Mini livers can be printed within 90 days

A new study suggests mini livers can be successfully printed in the laboratory within 90 days. This could have profound implications for transplant patients...

Latest articles

Building an artificial immune system

DoD-funded ThirdLaw Technologies to harness the power of ‘spiroligomers’ to rapidly build new small molecules for Longevity therapies. Far from the world of stock market...

Neurotech is the new blue ocean

Alon Braun, Co-Founder, Neurotech Analytics.

Amazon and K4Connect demonstrate scalability for agetech

Covid-19 has been difficult for everyone, but particularly for people over the age of 65 who may spend months shut away from loved ones...

“Avoid the use of DQ as a senolytic therapy”

Forever Healthy Foundation issues risk-benefit analysis on dasatinib + quercetin as a senolytic. The Forever Healthy Foundation today published its latest risk-benefit analysis, which explores...